Aurinia Pharmaceuticals AUPH Q1 2025 earnings
Reported May 12, 2025 · Before market open
Revenue$62.5MMiss by $2.2M
EPS$0.16Beat by $0.08
Revenue estimate$64.6M
EPS estimate$0.08
Next report
Jul 30, 2026 (Tomorrow)Revenue estimate$80.4M
EPS estimate$0.19
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Aurinia Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aurinia Pharmaceuticals report Q1 2025 earnings?
- Aurinia Pharmaceuticals (AUPH) reported Q1 2025 earnings on May 12, 2025 before market open.
- What were Aurinia Pharmaceuticals's Q1 2025 revenue and EPS?
- Aurinia Pharmaceuticals reported revenue of $62.5M and eps of $0.16 for Q1 2025.
- Did Aurinia Pharmaceuticals beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $64.6M by $2.2M. EPS beat the consensus estimate of $0.08 by $0.08.
- How did Aurinia Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 24.2% from $50.3M a year earlier.
- Where can I find Aurinia Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001600620-25-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.